Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors
- 31 October 1993
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 22 (4), 963-967
- https://doi.org/10.1016/0735-1097(93)90404-o
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Flosequinan, a new vasodilator: Systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failureJournal of the American College of Cardiology, 1992
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Future directions in vasodilator therapy for heart failureAmerican Heart Journal, 1991
- Exercise capacity, hemodynamic, and neurohumoral changes following acute and chronic administration of flosequinan in chronic congestive heart failureCardiovascular Drugs and Therapy, 1990
- Effect of flosequinan on exercise capacity and symptoms in severe heart failure.Heart, 1989
- Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.BMJ, 1988
- Cumulative Hemodynamic Response to Short-Term Treatment with Flosequinan (BTS 49465), a New Direct-Acting Vasodilator Drug, in Severe Chronic Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1988
- Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failureAmerican Heart Journal, 1987
- Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure.Circulation, 1985
- Nitrate therapy of heart failure in valvular heart diseaseAmerican Journal Of Medicine, 1978